Oxygen saturation in pregnant individuals with COVID-19: time for re-appraisal?
Where this comes from
- Record sourced from PubMed, PMID 34922921.
- Also identified by DOI 10.1016/j.ajog.2021.12.023 and PMC identifier 8675122.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Managing pregnant individuals with acute respiratory disease secondary to COVID-19 has been a challenge. Most professional societies including the Society for Maternal-Fetal Medicine recommend keeping O<sub>2</sub> saturation at ≥95% in pregnant individuals. Reaching this target has been increasingly difficult in some patients, especially during the latest wave of infections attributed to the delta variant of SARS-CoV-2. In the absence of adequate supporting data, and in the setting of a reassuring fetal status, we propose that maternal O<sub>2</sub> saturation should be maintained between 92% and 96% for admitted patients with acute respiratory failure who require supplemental O<sub>2</sub>. This may prevent unnecessary invasive interventions that might not hold maternal or fetal benefit, specifically at very preterm gestational ages.
Medical subject headings
- COVID-19
- Pregnancy Complications, Infectious
- Respiratory Distress Syndrome